Health
Heart Transplant ‘Liquid Biopsy’; PCSK9 CRISPR; More SGLT2 Drugs Try FDA in HF – MedPage Today
Recent developments of interest in cardiovascular medicine
A blood test showed promise as a “liquid biopsy” for detection of acute heart transplant rejection. (Circulation)
Early efforts to use CRISPR to edit PCSK9 genes in severe heterozygous familial hypercholesterolemia are moving forward. (Endpoints News)
In a study of 145 student athletes with no more than moderate COVID-19 symptoms, cardiac MRI a median 15 days after the positive test was consistent with myocarditis in two (1.4%). (JAMA Cardiology)
Each extra serving of fried foods per week was linked…
-
General18 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News22 hours agoMore children’s sand products from Kmart and Target recalled over asbestos contamination fears
-
General23 hours agoMore coloured sand products recalled as ACT set to announce when schools will reopen
-
Noosa News22 hours agoBurgess Creek to go weed free